经济观察网 根据截至2026年2月26日的公开信息，别样肉客（BYND.OQ）推出植物基功能饮料Beyond Immerse是其应对持续业绩压力的战略尝试，但能否扭转颓势仍面临多重挑战。 品牌认知固化：消费者对其认知高度绑定"植物肉"，新业务易被视作边缘尝试而非战略转型。 竞争壁垒：功能性饮料市场已有专业品牌占据，别样肉客在配方、口感优化及品牌信任度上存在差距。 产品研发进展 2026年1月，别样肉客推出首款非肉类产品Beyond Immerse，定位运动后恢复与日常营养补充，主打肌 肉修复、肠道健康及免疫支持功能。该产品以豌豆蛋白为核心原料，切入高速增长的高蛋白功能饮料赛 道。Innova Market Insights数据显示，2020年至2024年全球高蛋白奶昔和饮料新品数量增长122%， 且"全能蛋白"被列为2026年食品行业首要趋势。公司通过直销平台Beyond Test Kitchen限时发售，以低 成本测试市场反应，符合其现金流紧张的现状。 业绩经营情况 新品发布正值公司深度亏损期。财务数据显示，2022年至2024年营收从4.19亿美元降至3.26亿美元，同 期净亏损累计超8亿美元。2025年 ...

Core Viewpoint - Double Tower Food, the world's largest pea protein producer, is facing significant pressure on its performance, with a projected net profit decline of 70.41% to 57.72% for 2025 compared to the previous year due to challenges in overseas exports and a decrease in pea starch prices leading to asset impairment [1][3]. Financial Performance - The company anticipates a net profit of 28 million to 40 million yuan for 2025, reflecting a substantial decline [1]. - For the first three quarters of 2025, asset impairment losses reached -68.99 million yuan, an increase of 40.42% from the beginning of the period, attributed to rising starch inventory and increased provisions for inventory depreciation [3]. - In 2021 and 2022, the company's net profits were 268 million yuan and -311 million yuan, respectively, showing a year-on-year decline of 24.12% and 216% [4]. - In contrast, the company saw a recovery in 2023 and 2024, with net profits of 93 million yuan and 95 million yuan, representing year-on-year growth of 130% and 1.48% [4]. Market Challenges - The European Union initiated an anti-dumping investigation against Chinese pea protein on September 1, 2025, affecting products with protein content exceeding 65% on a dry weight basis, with the sales of affected products accounting for 3.92% of total revenue in 2024 and increasing to 6.48% in the first half of 2025 [3]. - The company is experiencing dual pressures from external trade friction and internal price cycles, which have highlighted its limited bargaining power in the supply chain and the vulnerability of its business structure [4]. Strategic Initiatives - The company is actively expanding into emerging international markets and enhancing its domestic market presence, with domestic sales revenue increasing by 15.63% year-on-year in the first half of 2025, raising its revenue share to 53.89% [4]. - The Thai factory has been completed and is now operational, contributing to the company's international expansion efforts [4]. Competitive Positioning - As a leader in the pea protein market, the company possesses scale production capacity and mature production technology, providing a competitive edge [5]. - However, the domestic market faces intense competition, and the company's previous focus on B2B rather than B2C has resulted in relatively weak brand influence and a limited product matrix [5]. - There is potential for the company to leverage its production advantages to penetrate the domestic plant-based milk and meat markets while enhancing brand development and product innovation [5].

Core Viewpoint - Beyond Meat is expanding from the plant-based meat sector into the beverage market with the launch of Beyond Immerse, a plant-based functional drink aimed at muscle recovery, gut health, and immune support [1][2] Group 1: Product Launch and Strategy - Beyond Immerse is made primarily from pea protein and includes tapioca fiber, vitamin C, and electrolytes, and is free from GMOs and sugar alcohols [1] - The drink is currently available exclusively on Beyond Meat's new direct sales website, Beyond Test Kitchen, with future retail expansion dependent on customer feedback [1] - This marks Beyond Meat's first non-meat product launch, driven by rising consumer interest in obtaining protein from various product forms [1][2] Group 2: Financial Performance - Beyond Meat has faced declining revenues and ongoing losses since 2022, with revenues of $419 million in 2022, $343 million in 2023, and projected $326 million in 2024, alongside losses of $366 million, $338 million, and $160 million respectively [2] - In the first three quarters of 2025, the company reported revenues of $214 million, a year-over-year decline of 14.37%, with net losses widening to $193 million [2] Group 3: Market Trends and Competitive Position - The launch of Beyond Immerse aligns with a growing market for high-protein beverages, which saw a 122% increase in product offerings from 2020 to 2024 [3] - Innova Market Insights identifies "Powerhouse Protein" as a key trend for 2026, with nearly 60% of global dining consumers actively seeking to increase protein intake [3] - Beyond Meat's competitive edge lies in its expertise in plant protein extraction and flavor masking technology, as well as its established supply chain for pea protein, which offers cost and quality advantages [3] Group 4: Industry Insights - Experts suggest that Beyond Meat's move into beverages is a short-term strategy to address performance pressures, while also representing a long-term trend of horizontal expansion in the plant protein category [4]

Core Viewpoint - Beyond Meat, known as the "first plant-based meat stock," is entering the beverage market with its new product, Beyond Immerse, a plant-based functional drink made primarily from pea protein, marking its first significant foray into functional foods and beverages [2][3] Expansion into Beverage Business - Beyond Meat has launched Beyond Immerse, a plant-based functional drink that includes pea protein, cassava fiber, vitamin C, and electrolytes, available in two protein versions (10g and 20g) with corresponding calorie counts of 60 and 100 [3] - The drink is offered in three flavors: Peach Mango, Lemon Lime, and Orange Tangerine, and is positioned for post-workout or daily supplementation, focusing on muscle recovery, gut health, and immune support [3] - Currently, Beyond Immerse is sold exclusively through Beyond Meat's new direct-to-consumer website, Beyond Test Kitchen, with future retail expansion contingent on customer feedback [3][4] Breaking Through "Plant Meat" Limitations - The launch of Beyond Immerse comes as Beyond Meat faces significant financial losses, with revenues declining from $419 million in 2022 to an expected $326 million in 2024, alongside increasing net losses [5][6] - The company aims to diversify its offerings beyond meat substitutes, with CEO Ethan Brown stating the goal is to become a "global protein company of the future" [6][7] Market Trends and Competitive Landscape - The global market for high-protein shakes and beverages has seen a 122% increase from 2020 to 2024, with a growing consumer interest in protein intake [8] - Traditional beverage giants and sports nutrition brands are also entering the high-protein plant-based beverage space, indicating a competitive landscape for Beyond Meat [8] - Despite the challenges, Beyond Meat's expertise in plant protein extraction and flavor masking, along with its sustainable brand image, positions it favorably against competitors [9] Strategic Positioning - The introduction of Beyond Immerse reflects a strategic shift towards product diversification and tapping into faster-growing markets, moving away from a sole focus on meat alternatives [7][8] - Industry experts suggest that while this move may be seen as a temporary measure due to financial pressures, it represents a necessary evolution towards a more resilient business model [9]

Core Insights - Beyond Meat has officially entered the beverage market with the launch of Beyond Immerse, a plant-based functional drink made primarily from pea protein, marking its first significant foray into functional foods and beverages [1][2] - The company aims to diversify beyond its core plant-based meat products amid ongoing revenue declines, seeking new growth avenues [1][4] Product Details - Beyond Immerse features two protein versions (10g and 20g) with corresponding calorie counts of 60 and 100, and includes 7g of dietary fiber, with no GMOs or sugar alcohols [2] - The drink is available in three flavors: Peach Mango, Lemon Lime, and Orange Tangerine, and is positioned for post-workout or daily consumption, focusing on muscle recovery, gut health, and immune support [2] Market Context - The launch comes at a time when Beyond Meat is experiencing significant financial losses, with revenues dropping from $419 million in 2022 to an expected $326 million in 2024, alongside increasing net losses [4][5] - The global plant-based meat industry is facing a downturn, with a 64% drop in venture capital investment in 2024, leading to challenges for companies like Nestlé and Unilever, which have scaled back their plant-based meat operations [5] Strategic Shift - Beyond Meat is shifting its brand focus from meat alternatives to traditional plant proteins, gradually phasing out the "Meat" designation from its branding [6] - The introduction of Beyond Immerse reflects a deeper strategy to diversify product offerings and tap into faster-growing markets [6][7] Competitive Landscape - The high-protein beverage market is rapidly expanding, with a reported 122% growth in high-protein shakes and drinks from 2020 to 2024, indicating a strong consumer interest in protein intake [7] - Competitors in the beverage space include major brands like Danone and Protein Works, which have launched their own high-protein plant-based drinks [7] Consumer Insights - The company is leveraging a Direct-To-Consumer (DTC) model through its new website, Beyond Test Kitchen, to test market acceptance and gather consumer feedback, which is crucial given its current cash flow challenges [3][8] - Despite the potential for growth, there is a risk that consumers may still associate Beyond Meat primarily with plant-based meat, which could hinder the acceptance of its new beverage line [8]

Core Viewpoint - New Hope Dairy has shown a positive stock performance with a year-to-date increase of 5.09% and significant gains over various trading periods, indicating a strong market interest in the company [2]. Group 1: Stock Performance - As of January 19, New Hope Dairy's stock price increased by 2.05%, reaching 19.40 CNY per share, with a total market capitalization of 16.697 billion CNY [1]. - The stock has experienced a 4.30% increase over the last five trading days, a 7.12% increase over the last 20 days, and a 13.12% increase over the last 60 days [2]. Group 2: Financial Performance - For the period from January to September 2025, New Hope Dairy reported a revenue of 8.434 billion CNY, reflecting a year-on-year growth of 3.49%, while the net profit attributable to shareholders was 623 million CNY, marking a significant increase of 31.48% [2]. - Since its A-share listing, New Hope Dairy has distributed a total of 737 million CNY in dividends, with 508 million CNY distributed over the past three years [3]. Group 3: Shareholder Information - As of January 9, 2025, the number of shareholders for New Hope Dairy increased by 1.88% to 13,400, while the average number of circulating shares per shareholder decreased by 1.85% to 63,647 shares [2]. - Notable institutional shareholders include China Europe Value Select Mixed Fund, which increased its holdings by 2.0809 million shares, and Huatai-PB Vision Select Mixed Fund, which is a new shareholder with 3.8481 million shares [3].

Core Viewpoint - Junyao Health's stock has experienced fluctuations, with a year-to-date increase of 19.29% but a recent decline in the last five trading days by 8.06% [1] Group 1: Stock Performance - As of December 30, Junyao Health's stock price was 7.41 yuan per share, with a market capitalization of 4.45 billion yuan [1] - The stock has seen a trading volume of 64.53 million yuan and a turnover rate of 1.44% [1] - The stock has appeared on the daily trading list 12 times this year, with the most recent appearance on December 15, where it recorded a net purchase of 26.57 million yuan [1] Group 2: Company Overview - Junyao Health, established on August 5, 1998, and listed on August 18, 2020, is based in Shanghai and specializes in the research, production, and sales of room-temperature lactic acid bacteria beverages [2] - The company's revenue composition includes probiotic beverages (34.11%), commodity supply chain (34.07%), probiotic foods (21.98%), and other beverages and foods (9.55%) [2] - As of September 30, the number of shareholders was 34,300, a decrease of 19.52% from the previous period [2] Group 3: Financial Performance - For the period from January to September 2025, Junyao Health reported a revenue of 1.095 billion yuan, a year-on-year decrease of 6.95%, and a net profit attributable to shareholders of -2.37 million yuan, a decrease of 104.79% [2] - The company has distributed a total of 365 million yuan in dividends since its A-share listing, with 132 million yuan distributed in the last three years [3] Group 4: Institutional Holdings - As of September 30, 2025, Tianhong Zhongzheng Food and Beverage ETF was the tenth largest circulating shareholder, holding 948,500 shares, an increase of 116,700 shares from the previous period [3]

Group 1 - The core viewpoint of the news is that Junyao Health's stock has experienced fluctuations, with a recent decline in share price and significant trading activity, indicating investor sentiment and market dynamics [1][2]. - As of December 25, Junyao Health's stock price was 7.82 yuan per share, with a market capitalization of 4.696 billion yuan. The stock has increased by 25.89% year-to-date but has seen a decline of 3.58% in the last five trading days [1]. - The company has been active in the market, appearing on the trading leaderboard 12 times this year, with the most recent net buy of 26.57 million yuan on December 15 [1]. Group 2 - Junyao Health, established on August 5, 1998, and listed on August 18, 2020, specializes in the research, production, and sales of ambient lactic acid drinks and other health beverages [2]. - The company's revenue composition includes probiotic drinks (34.11%), supply chain products (34.07%), probiotic foods (21.98%), and other beverages and foods (9.55%) [2]. - As of September 30, 2025, Junyao Health reported a revenue of 1.095 billion yuan, a year-on-year decrease of 6.95%, and a net profit attributable to shareholders of -2.3688 million yuan, a decrease of 104.79% [2]. Group 3 - Junyao Health has distributed a total of 365 million yuan in dividends since its A-share listing, with 132 million yuan distributed over the past three years [3]. - As of September 30, 2025, the number of shareholders decreased by 19.52% to 34,300, while the average circulating shares per person increased by 24.25% to 17,487 shares [2][3]. - The top ten circulating shareholders include Tianhong Zhongzheng Food and Beverage ETF, which increased its holdings by 11.67% to 948,500 shares [3].

Group 1 - The core viewpoint of the news is that Liziyuan's stock has experienced fluctuations, with a current price of 12.45 CNY per share and a market capitalization of 4.857 billion CNY, reflecting a year-to-date increase of 17.86% [1] - As of December 23, Liziyuan's main funds have seen a net outflow of 757,000 CNY, with significant selling activity [1] - The company has appeared on the "Dragon and Tiger List" once this year, with the last appearance on April 17, showing a net buy of -3.7008 million CNY [1] Group 2 - Liziyuan Food Co., Ltd. was established on October 22, 1994, and went public on February 8, 2021, focusing on the research, production, and sales of dairy beverages [2] - The company's main business revenue composition includes 93.76% from dairy beverages, 4.86% from other products, and minimal contributions from flavored drinks and protein beverages [2] - As of September 30, the number of shareholders increased by 12.53% to 35,200, while the average circulating shares per person decreased by 12.11% [2] Group 3 - Since its A-share listing, Liziyuan has distributed a total of 745 million CNY in dividends, with 570 million CNY distributed over the past three years [3]

Core Viewpoint - The stock price of Huanlejia has shown significant growth this year, with a year-to-date increase of 114.86%, and recent trading activity indicates continued interest from investors [2]. Group 1: Stock Performance - Huanlejia's stock price decreased by 2.37% to 32.60 CNY per share on December 22, with a trading volume of 3.08 billion CNY and a turnover rate of 2.39% [1]. - The stock has increased by 17.52% over the last five trading days, 46.06% over the last 20 days, and 68.39% over the last 60 days [2]. - The company has appeared on the stock market's "龙虎榜" (top trading list) six times this year, with the most recent appearance on December 16 [2]. Group 2: Company Overview - Huanlejia Food Group Co., Ltd. is located in Zhanjiang, Guangdong Province, and was established on December 12, 2001, with its stock listed on June 2, 2021 [2]. - The company's main business includes the research, production, and sales of canned fruits, plant protein beverages, fruit juices, and lactic acid bacteria beverages, with revenue composition being 55.73% from beverages, 38.66% from canned goods, and 5.61% from other products [2]. - Huanlejia belongs to the food and beverage industry, specifically in the soft drink sector, and is associated with concepts such as plant protein, mid-cap stocks, margin financing, historical highs, and rural revitalization [2]. Group 3: Financial Performance - For the period from January to September 2025, Huanlejia reported a revenue of 1.042 billion CNY, a year-on-year decrease of 22.25%, and a net profit attributable to shareholders of 10.53 million CNY, down 87.43% year-on-year [2]. - The company has distributed a total of 477 million CNY in dividends since its A-share listing, with 346 million CNY distributed over the past three years [3]. - As of September 30, 2025, Huanlejia had 18,600 shareholders, a slight decrease of 0.11%, with an average of 20,802 circulating shares per shareholder, which increased by 0.11% [2].